Lisa I Backus
- A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis CLisa I Backus
Center for Quality Management in Public Health, Veterans Affairs Palo Alto Health Care System, California, USA
Clin Gastroenterol Hepatol 9:509-516.e1. 2011..The impact of SVR on all-cause mortality is not well documented by HCV genotype or in populations in routine medical practice with substantial comorbidities...
- National quality forum performance measures for HIV/AIDS care: the Department of Veterans Affairs' experienceLisa I Backus
Center for Quality Management in Public Health, Veterans Affairs Palo Alto Health Care System, 3801 Miranda Ave, Palo Alto, CA 94304, USA
Arch Intern Med 170:1239-46. 2010..We assessed performance using available electronic data for the large, diverse population with HIV in the Department of Veterans Affairs (VA) and evaluated the influence of patient and resource factors...
- Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virusL I Backus
Center for Quality Management in Public Health Veterans Health Administration, Palo Alto, CA 94304, USA
J Viral Hepat 13:799-810. 2006..More research is needed to determine if the observed racial differences in starting HCV treatment reflect biological differences, provider behaviour or patient preference...
- Predictors of response of US veterans to treatment for the hepatitis C virusLisa I Backus
Center for Quality Management in Public Health, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA
Hepatology 46:37-47. 2007..For genotype 3 patients, only receiving PEG-INF 2A affected the likelihood of an SVR; its effect was positive...
- Clinical Case Registries: simultaneous local and national disease registries for population quality managementLisa I Backus
Center for Quality Management in Public Health, Palo Alto HCS, 3801 Miranda Avenue 132, Palo Alto, CA 94304, USA
J Am Med Inform Assoc 16:775-83. 2009..Local and national reports covering demographics, resource usage, quality of care metrics and medication safety issues have been generated...
- Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelinesElizabeth W Hwang
Population Health Program Office of Public Health, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
J Clin Gastroenterol 47:264-70. 2013..As representative of overall provider adherence to practice guidelines, provider adherence to specific recommendations regarding rapid virologic response (RVR) was assessed...
- Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis CPamela S Belperio
Population Health Program Office of Public Health, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304, USA
Clin Gastroenterol Hepatol 11:1021-7. 2013..We aimed to evaluate real-world experience with DAA-based regimens...
- Postmarketing use of enfuvirtide in veterans: provider compliance with criteria for use, overall efficacy, and tolerabilityPamela S Belperio
Center for Quality Management in Public Health, Palo Alto, CA, USA
Ann Pharmacother 42:1573-80. 2008..Because of its uniqueness, the Veterans Health Administration (VHA) implemented specific enfuvirtide prescribing and follow-up criteria (criteria for use; CFU) and then assessed providers' compliance with these criteria and outcomes...
- Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapyLisa I Backus
Center for Quality Management in Public Health, Veterans Health Administration, Palo Alto, CA 94304, USA
J Acquir Immune Defic Syndr 39:613-9. 2005..Several studies have investigated the effect of coinfection on mortality, with conflicting results...
- Provider prescribing of 4 antiretroviral agents after implementation of drug use guidelines in the Department of Veterans AffairsPamela S Belperio
Center for Quality Management in Public Health, Department of Veterans Affairs, 3801 Miranda Ave M C 132, Palo Alto, CA 94304, USA
J Manag Care Pharm 15:323-34. 2009..These criteria are disseminated to all VHA facilities...
- HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populationsLisa I Backus
Center for Quality Management in Public Health, US Department of Veterans Affairs, Palo Alto, CA, USA
AIDS 19:S13-9. 2005....
- Trends in uptake of recently approved antiretrovirals within a national healthcare systemP S Belperio
Department of Veterans Affairs, Center for Quality Management in Public Health, Palo Alto, CA, USA
HIV Med 11:209-15. 2010..The aim of the study was to describe Veterans Healthcare Administration (VHA) system-wide uptake of three HIV protease inhibitors: atazanavir, darunavir and tipranavir...
- Surveyed Enrollees in Veterans Affairs Health Care: How They Differ From Eligible Veterans Surveyed by BRFSSBarbara R Phillips
Population Health Program, Office of Public Health, Veterans Health Administration, 3801 Miranda Avenue, Palo Alto, CA 94304
Mil Med 180:1161-9. 2015..Knowledge of these differences is important in planning better services for Veterans who enroll and in encouraging additional enrollment...
- Cigarette Smoking, Reduction and Quit Attempts: Prevalence Among Veterans With Coronary Heart DiseaseTroy A Shahoumian
Population Health Program, Palo Alto Veterans Health Care System, 3801 Miranda Ave, Palo Alto, CA 94304 Email
Prev Chronic Dis 13:E41. 2016..To inform assessment of efforts to reduce smoking, we sought to provide prevalence rates for smoking behaviors among US veterans with coronary heart disease and to compare rates for veterans with those for civilians...
- Impact of provider type on hepatitis C outcomes with boceprevir-based and telaprevir-based regimensLisa I Backus
Office of Public Health Population Health Department of Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA
J Clin Gastroenterol 49:329-35. 2015..To examine the effect of provider type on outcomes and safety in a large hepatitis C virus (HCV)-infected cohort treated in routine medical practice...
- A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care systemPamela S Belperio
Department of Veterans Affairs, 3801 Miranda Ave 132, Palo Alto, CA 94304
J Manag Care Spec Pharm 20:533-40. 2014..Comparative safety and effectiveness data in real-world populations upon which to make formulary decisions did not exist...
- Retention in care: a challenge to survival with HIV infectionThomas P Giordano
Baylor College of Medicine, Houston, Texas, USA
Clin Infect Dis 44:1493-9. 2007..Patients with human immunodeficiency virus (HIV) infection need lifelong medical care, but many do not remain in care. The effect of poor retention in care on survival is not known, and we sought to quantify that relationship...